Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Surface Oncology's IPO nets $100.4mm

Executive Summary

Surface Oncology Inc. (next-generation cancer immunotherapies targeting the tumor microenvironment) netted $100.4mm through its initial public offering of 7.2mm common shares at $15. (The company originally intended to sell 6mm shares at a range of $13-15.)
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies